Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid in obese patients with or without elevated free fatty acids
ChiCTR-TRC-10000846Phase 4Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alpha-lipoic acid in obesity, insulin resistance (IR) and Beta-cell dysfunction (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoints: Malondialdehyde, Interleukin-6 and 2 more. Started Nov 2009; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
obesityinsulin resistance (IR)Beta-cell dysfunction
Beyond the preview
Go deeper on ChiCTR-TRC-10000846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000846.